USA 1-800-227-2862 (BBRAUN2)
U.S.A.
 
Home > Press > Company News

Company News

   

Read news and press releases about B. Braun Medical Inc. (B.Braun), covering subjects ranging from products, related events, company news and more.

05/15/2015

B. Braun To Sponsor Exhibitor Theater Presentation at INS

Robust Safety-Engineered IV Therapy Portfolio To Be Featured During INS — Company Committed To Improving Vascular Access, Patient and Healthcare Worker Safety

BETHLEHEM, PA – May 15, 2015 – B. Braun Medical Inc. (B.Braun) will sponsor an Exhibitor Theater presentation at the Infusion Nursing Society (INS) 2015 Annual Convention and Industrial Exhibition in Louisville, KY, May 18th-20th. The presentation, “Driving Performance Improvement in Ultrasound Guided Peripheral Access: Navigating the Procedure and Process,” will focus on defining which peripheral catheter should be used for insertion based on tip position and vein selection, a review of standards and current evidence on how to use peripheral catheters to achieve optimal results and highlight when, why, and how to insert peripheral devices with ultrasound guidance.

Robert B. Dawson, DNP, MSA, APRN, ACNP--BC, CPUI, VA-BC, CEO Vascular Access Consultants, LLC, will be the featured presenter. The presentation will take place on Monday, May 18th from 1:10 p.m. – 2:00 p.m. in the exhibit hall. For more details on this presentation, visitwww.bbrauninsspring.com.
Mr. Dawson will also be the featured expert at B.Braun’s booth (#321) where he will demonstrate IV catheter insertion using ultrasound guidance on Monday, May 18th (10:00 a.m. – 12:30 p.m.) and Tuesday, May 19th (10:00 a.m. – 2:00 p.m.)
Catheter-related bloodstream infections (CRBSIs), needlestick (sharps) injuries and exposure to potentially deadly blood borne pathogens continue to be major issues facing all healthcare professionals.

“B.Braun is passionately committed to addressing and combating these issues by providing innovative safety-engineered IV therapy devices that offer patient protection against infection and optimum safety for clinicians in the workplace,” said Tom Sutton, Vice President of Vascular Access Systems at B.Braun. “We also support improving clinical outcomes by advocating for the use of ultrasound guided peripheral access,” added Sutton.

B.Braun will also showcase its family of safety-engineered IV therapy devices at booth (#321) during INS:

  • Introcan Safety® IV Catheter, which is designed with innovative automatic, passive-safety features to help eliminate accidental needlestick injury - effortlessly. From insertion to catheter deployment to needle removal, clinicians are protected by a truly passive safety device that is activated automatically - no extra steps required and cannot be bypassed. 
  • Introcan Safety® 3 Closed IV Catheter, B.Braun’s latest innovation, which takes the same preferred passive safety-engineered needlestick protection found in Introcan Safety and adds additional protection from blood exposure. For safety and convenience, the Introcan Safety 3's unique automatic, multi-access blood control septum minimizes blood exposure during needle removal and each time the catheter hub is accessed. 
  • InVision-Plus® Neutral IV Connector, the latest addition to the B.Braun needleless connector portfolio through an exclusive U.S. distribution agreement with RyMed Technologies, LLC, provides a 10-point standard of features. B.Braun’s portfolio of needleless connectors, including the CARESITE® Luer Access Device, offers a safe way to access IV lines through innovative features designed to help reduce catheter occlusions while protecting healthcare workers from accidental needlestick injuries. 
  • OnGuard™ Closed Medication System with Tevadaptor® Components, a next-generation closed system drug-transfer device (CSTD), underscores B.Braun’s commitment to helping protect healthcare workers from exposure to hazardous drugs. It meets the National Institute for Occupational Safety and Health definition of a CSTD in actual drug testing with antineoplastic agents. To learn more about hazardous drug exposure and to download an educational poster visit www.cytotoxicExposure.com 
  • Coming Soon – Ster-ASSIST™ Sterile Peripheral IV Catheter Insertion Kit. Success in peripheral IV therapy can now be realized in one, comprehensive kit supporting sterile and ultrasound-guided procedures.

About B. Braun
B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The Company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. Guided by its “Sharing Expertise®” philosophy, B.Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs.

The B.Braun Group of Companies in the U.S. includes B.Braun, B.Braun Interventional Systems, Aesculap® and CAPS®. B.Braun’s U.S. headquarters is located in Bethlehem, Pennsylvania. The B.Braun Group of Companies employs more than 50,000 employees in more than 60 countries throughout the world. To learn more about B.Braun visit www.BBraunUSA.com.